Member Directory

Gertrude Biomedical Pty Ltd

Website: https://www.gertrudebiomed.com/

Member Contact: Dr Tara Karnezis

Position: CEO & Managing Director

Industry: Biotech & Pharmaceuticals

Company Profile:

Gertrude Biomedical is a private, early-stage drug discovery and development company based at the Bio21 Institute in Parkville, Melbourne. The company is developing small molecule inhibitors to SOX18, a transcription factor target which regulates gene pathways to manipulate cell growth/differentiation, inflammation and angiogenesis.

Gertrude Biomedical is focused on developing drugs to treat two indications of significant unmet need, Kaposi Sarcoma and Angiosarcoma, however, the multi-functional nature of SOX18 translates to significant commercial and clinical potential beyond orphan indications.

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.